The US Centers for Disease Control and Prevention (CDC) filed a lawsuit against Gilead Sciences for patent infringement on Truvada and Descovy, which are used as pre-exposure prophylaxis (PrEP) for HIV prevention.
Drug use is prevalent in prison systems worldwide, and the levels of HIV and hepatitis C, which can be transmitted through drug injection and sex, are also higher among people in prisons than the general population. However, prisons are often overlooked in efforts to combat these epidemics.
Leggat et al. report the results of a phase 1 clinical trial showing that a germline-targeting priming immunogen was safe and feasible and induced targeted bnAb-precursor responses in 97% of vaccine recipients at substantial frequencies in each individual
The first preclinical studies have shown that the method cleans infected cells from "sleeping" HIV by 100%.
A person with HIV is in long-term viral remission after intensive treatment
Preliminary tests have shown that these drugs do not reduce or practically do not reduce mortality among patients with coronavirus.
The agreement between Gilead and five generic pharmaceutical companies in India and Pakistan will help make the medicine for 127 countries.
В женский день скидка для женщин 5% на все заказы!
До конца июля 2019 г. вы можете заказать любой продукт и оплатить его при получении по цене "экспресс-доставки" и по цене "без таможни". За подробностями обращайтесь по телефону +6281237935373 (whatsapp, viber).